Patents by Inventor Mustapha Abarghaz

Mustapha Abarghaz has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Compounds, preparation and therapeutic use thereof
    Publication number: 20090215752
    Abstract: The invention relates to benzodiazepine derivatives having PDE2 inhibitory activities, as well as therapeutic methods of administering said compounds, in particular for treating various diseases of the central or peripheral nervous system. The invention further includes methods of preparing the subject compounds and pharmaceutical compositions containing them.
    Type: Application
    Filed: August 2, 2006
    Publication date: August 27, 2009
    Inventors: Mustapha Abarghaz, Stefano Biondi, Jérôme Duranton
  • Benzo-1,4-diazepin-2-one derivatives as phosphodiesterase PDE2 inhibitors, preparation and therapeutic use thereof
    Patent number: 7410963
    Abstract: The invention relates to compounds having PDE2 inhibitory activities, as well as therapeutic methods by administering said compounds, in particular for treating various diseases of the central or peripheral nervous system. It further deals with pharmaceutical compositions comprising said compounds and methods for preparing said compounds.
    Type: Grant
    Filed: December 23, 2004
    Date of Patent: August 12, 2008
    Assignee: VIA Pharmaceuticals, Inc.
    Inventors: Mustapha Abarghaz, Stefano Biondi, Jérôme Duranton, Emmanuelle Limanton, Cesare Mondadori, Patrick Wagner
  • Benzo-1,4-diazepin-2-one derivatives as phosphodiesterase pde2 inhibitors, preparation and therapeutic use thereof
    Publication number: 20070123519
    Abstract: The invention relates to compounds having PDE2 inhibitory activities, as well as therapeutic methods by administering said compounds, in particular for treating various diseases of the central or peripheral nervous system. It further deals with pharmaceutical compositions comprising said compounds and methods for preparing said compounds.
    Type: Application
    Filed: December 23, 2004
    Publication date: May 31, 2007
    Inventors: Mustapha Abarghaz, Stefano Biondi, Jerome Duranton, Emmanuelle Limanton, Cesare Mondadori, Patrick Wagner
  • Compositions derived from quinoline and quinoxaline, preparation and use thereof
    Publication number: 20060183909
    Abstract: The present invention concerns compounds derived from quinoline and quinoxaline, their preparation and their uses, particularly in the field of therapeutics and vaccines or for developing active compounds. The inventive compounds are of general formula (I), and their pharmaceutically acceptable salts.
    Type: Application
    Filed: July 19, 2002
    Publication date: August 17, 2006
    Inventors: Martine Schmitt, Evelyne Klotz, Jean-Paul Macher, Jean-Jacques Bourguignon, Mustapha Abarghaz, Patrick Wagner, Gael Ronsin
  • Cyclic nucleotide phosphodiesterase inhibitors, preparation and uses
    Publication number: 20060128695
    Abstract: The invention concerns the use of PDE2 inhibitors for treating disorders of the central and peripheral nervous system, a method for therapeutic treatment by administering to an animal said inhibitors. More specifically, the invention concerns novel benzodiazepinone derivatives and their uses in therapeutics more particularly for treating pathologies involving activity of a cyclic nucleotide phosphodiesterase type 2. The invention also concerns methods for preparing same and novel synthesis intermediates.
    Type: Application
    Filed: October 30, 2003
    Publication date: June 15, 2006
    Applicants: NEURO3D, UNIVERSITE LOUIS PASTEUR
    Inventors: Jean-Jacques Bourguignon, Claire Lugnier, Mustapha Abarghaz, Yan Lagouge, Patrick Wagner, Cesare Mondadori, Jean-Paul Macher, Dominique Schultz, Pierre Raboisson